• See how Step Pharma is leveraging data-driven discovery of replication stress as a predictive biomarker, linking novel agents with ATR and WEE1 synergy

• Sharing preclinical insights while outlining the translational challenges of moving from complex preclinical signatures to clinical assays

• Balancing biomarker complexity with clinical feasibility to inform future DDR combination strategies